Skip to main content
Clinical Trials/NCT06584695
NCT06584695
Not yet recruiting
Not Applicable

Analgesic Efficacy of External Oblique Intercostal Block Versus Subcostal Transversus Abdominis Plane Block in Open Surgical Nephrectomy

Cairo University1 site in 1 country63 target enrollmentSeptember 10, 2024

Overview

Phase
Not Applicable
Intervention
Transversus abdominis plane block
Conditions
Analgesic Efficacy
Sponsor
Cairo University
Enrollment
63
Locations
1
Primary Endpoint
Degree of pain
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

To compare the efficacy of unilateral ultrasound-guided oblique subcostal transversus abdominis plane block with unilateral ultrasound-guided external oblique intercostal plane block in providing intraoperative and postoperative analgesia in cancer patients undergoing open nephrectomy.

Detailed Description

Open surgery remains one of the procedures used for those patients requiring partial or radical nephrectomy and is associated with a high incidence of severe immediate postoperative pain and chronic pain the months following surgery. Regional anesthesia techniques are frequently recommended for pain control in open nephrectomy as they decrease the need for parenteral opioid and improve patient satisfaction. Although abdominal wall blocks are known to decrease opioid requirements without causing epidural associated hypotension, their role in flank surgeries has been less well-established. The dermatomes that need to be covered in flank incision are T9 to T11. Studies have confirmed that ultrasound-guided (USG) transversus abdominis plane (TAP) block is an effective method of analgesia for upper abdominal surgeries, lower abdominal surgeries and kidney transplantation with minimal side effects. The external oblique intercostal (EOI) block is a novel method providing simple and effective somatic analgesia to the upper abdomen with minimal side effects. Other advantages include easy sonoanatomy (even in obese patients), being performed in the supine position, and no anticoagulation concern

Registry
clinicaltrials.gov
Start Date
September 10, 2024
End Date
February 1, 2025
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Ahmed Abdelbaset Mostafa

Specialist of Anesthesia, Surgical Intensive Care & Pain Relief

Cairo University

Eligibility Criteria

Inclusion Criteria

  • Age (18-65) year.
  • Both sexes.
  • American Society of Anesthesiologists (ASA) class II and III.
  • Cancer patients candidate for open nephrectomy .

Exclusion Criteria

  • Patient refusal.
  • Skin lesions or infection at the site of proposed needle insertion.
  • Cognitive disorders.
  • History of psychiatric disorders or drug abuse.
  • Patients allergic to medication used.
  • ASA class IV.
  • Coagulopathy.
  • Body mass index (BMI) more than 35.

Arms & Interventions

Transversus abdominis plane group

patients will receive unilateral ultrasound-guided oblique subcostal transversus abdominis plane block block

Intervention: Transversus abdominis plane block

External oblique intercostal group

Patients will receive unilateral ultrasound-guided external oblique intercostal block

Intervention: External Oblique Intercostal Plane Block

Control group

Patients will receive IV morphine 0.1mg/kg after induction of general anesthesia.

Intervention: Control group

Outcomes

Primary Outcomes

Degree of pain

Time Frame: 24 hours after surgery

Degree of pain by Numerical rating scale (NRS)score. NRS (0 pain represents "no pain" while 10 pain represents "the worst pain imaginable"). scores will be registered at rest and movement immediately after surgery and at two, six, 12 and 24 hours after surgery, when the (NRS) was \> 4, IV morphine PCA will be initiated with continuous rate of 1 mg/hr, a patient demand bolus of 1mg and with lockout time of 10 minutes based on the patient weight and gender. the first time to the rescue analgesia needed and the top up doses will be recorded.

Secondary Outcomes

  • Mean arterial pressure(Till the end of surgery (up to 2hours))
  • Heart rate(Till the end of surgery (up to 2hours))
  • Opioids consumption(24 hours after surgery)
  • Morphine consumption(24 hours after surgery.)
  • Time to rescue analgesia.(24 hours after surgery)
  • Incidence of complications(24 hours after surgery)

Study Sites (1)

Loading locations...

Similar Trials